Research > Other lines

Other lines

Number of publications
558
Publications search
  • Sanahuja, J; Alonso, N; Diez, J; Ortega, E; Rubinat, E; Traveset, A; Alcubierre, N; Betriu À; Castelblanco, E; Hernandez, M; Purroy, F; Arcidiacono, MV; Jurjo, C; Fernandez, E; Puig-Domingo, M; Groop, PH; Mauricio, D

    Increased Burden of Cerebral Small Vessel Disease in Patients With Type 2 Diabetes and Retinopathy

    Diabetes Care 39 1614-1620. .

    [doi:10.2337/dc15-2671]

  • Pérez-Calvo, JI; Morales-Rull, JL; Gimeno-Orna, JA; Lasierra-Díaz, P; Josa-Laorden, C; Puente-Lanzarote, JJ; Bettencourt, P; Pascual-Figal, DA

    Usefulness of the Hepatocyte Growth Factor as a Predictor of Mortality in Patients Hospitalized With Acute Heart Failure Regardless of Ejection Fraction

    AMERICAN JOURNAL OF CARDIOLOGY 118 543-549. .

    [doi:10.1016/j.amjcard.2016.05.048]

  • Marquez-Medina D; Popat S

    Closing faucets: the role of anti-angiogenic therapies in malignant pleural diseases

    CLINICAL & TRANSLATIONAL ONCOLOGY 18 760-768. .

    [doi:10.1007/s12094-015-1464-y]

  • Domingo, P; Vidal, F

    Atazanavir dose reduction: one size does not fit all

    Lancet HIV 3 334-335. .

    [doi:10.1016/S2352-3018(16)30018-2]

  • Yeramian A; García V; Bergadà L; Domingo M; Santacana M; Valls J; Martinez-Alonso M; Carceller JA; Cussac AL; Dolcet X; Matias-Guiu X

    Bioluminescence Imaging to Monitor the Effects of the Hsp90 Inhibitor NVP-AUY922 on NF-kappa B Pathway in Endometrial Cancer

    MOLECULAR IMAGING AND BIOLOGY 18 545-556. .

    [doi:10.1007/s11307-015-0907-8]

  • Sanchez-de-la-Torre, A; Abad, J; Duran-Cantolla, J; Mediano, O; Cabriada, V; Masdeu, MJ; Teran, J; Masa, JF; de la Peña M; Aldoma, A; Worner, F; Valls, J; Barbe, F; Sanchez-de-la-Torre, M; Spanish Sleep Group

    Effect of Patient Sex on the Severity of Coronary Artery Disease in Patients with Newly Diagnosis of Obstructive Sleep Apnoea Admitted by an Acute Coronary Syndrome

    PLOS ONE 11 -. .

    [doi:10.1371/journal.pone.0159207]

  • Trullàs JC; Morales-Rull JL; Casado J; Ramírez AF; Manzano L; Formiga F

    Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure

    Journal Of Cardiac Failure 22 529-536. .

    [doi:10.1016/j.cardfail.2015.11.003]

  • van Dongen-Lases, EC; Cornes, MP; Grankvist, K; Ibarz, M; Kristensen, GBB; Lippi, G; Nybo, M; Simundic, AM; Working Grp Preanalytical Phase WG; European Federation Clinical Chem

    Patient identification and tube labelling - a call for harmonisation

    CLINICAL CHEMISTRY AND LABORATORY MEDICINE 54 1141-1145. .

    [doi:10.1515/cclm-2015-1089]

  • Lecube, A; Sanchez, E; Gomez-Peralta, F; Abreu, C; Valls, J; Mestre, O; Romero, O; Martinez, MD; Sampol, G; Ciudin, A; Hernandez, C; Simo, R

    Global Assessment of the Impact of Type 2 Diabetes on Sleep through Specific Questionnaires. A Case-Control Study

    PLOS ONE 11 -. .

    [doi:10.1371/journal.pone.0157579]

  • Alcubierre, N; Navarrete-Munoz, EM; Rubinat, E; Falguera, M; Valls, J; Traveset, A; Vilanova, MB; Marsal, JR; Hernandez, M; Granado-Casas, M; Martinez-Gonzalez, D; Jurjo, C; Franch-Nadal, J; Vioque, J; Mauricio, D

    Association of low oleic acid intake with diabetic retinopathy in type 2 diabetic patients: a case-control study

    Nutrition & Metabolism 13 40-40. .

    [doi:10.1186/s12986-016-0099-5]

  • Loupakis F; Stein A; Ychou M; Hermann F; Salud A; Österlund P

    A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer

    TARGETED ONCOLOGY 11 293-308. .

    [doi:10.1007/s11523-015-0400-y]

  • Krop, IE; Mayer, IA; Ganju, V; Dickler, M; Johnston, S; Morales, SN; Yardley, DA; Melichar, B; Forero-Torres, A; Lee, SC; de Boer, R; Petrakova, K; Vallentin, S; Perez, EA; Piccart, M; Ellis, M; Winer, E; Gendreau, S; Derynck, M; Lackner, M; Levy, G; Qiu, JH; He, J; Schmid, P

    Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial

    LANCET ONCOLOGY 17 811-821. .

    [doi:10.1016/S1470-2045(16)00106-6]